Prescription Orthopedic Drugs Global Market Report 2025
상품코드:1815893
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
처방용 정형외과 의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연평균 복합 성장률(CAGR)은 5.8%를 나타내 638억 6,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 생물제제 수요 증가, 노인 인구 증가, 신흥국 시장의 건강 관리 접근 확대, 만성 근골격계 장애의 유병률 상승, 정형외과용 의약품의 연구개발 투자 증가로 인한 것으로 예측됩니다. 예측 기간의 주요 동향으로는 표적 생물제제의 진보, 재생의료요법의 채용, 개별화된 약제제제, 저침습 전달법의 진보, 유전자 치료에 의한 약효증강, 주사제제제의 혁신, 약제개발과 임상 의사결정을 위한 인공지능의 혁신 등을 들 수 있습니다.
향후 5년간의 성장률 5.8%라고 하는 예측은 이 시장의 전회 예측으로부터 0.3%라는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 스웨덴과 한국에서 수입되는 관절내 보충요법 주사제나 골치유생물제제의 비용을 상승시키고, 수술 후 회복을 지연시키거나, 근골격계의 치료비를 상승시킬 수 있기 때문에 스포츠의학 진료에 큰 과제를 초래할 수 있습니다. 또한 상호관세와 무역긴장의 고조와 제한에 의한 세계경제와 무역에 대한 악영향에 의해 그 영향은 보다 넓게 느껴질 것입니다.
근골격계 장애의 유병률 증가는 처방용 정형외과 의약품 시장 확대를 촉진할 것으로 예측됩니다. 근골격계 장애(MSD)는 근육, 힘줄, 인대, 신경, 관절을 포함한 신체의 근골격계의 움직임과 기능에 영향을 미치고 통증과 움직임 제한으로 이어지는 상해와 상태를 포함합니다. 이러한 장애의 발생이 증가하는 이유는 노화, 반복 운동 및 어색한 자세를 동반하는 직업 활동, 좌석없는 라이프 스타일, 불충분 한 영양, 유전 적 소인 등의 요인 때문입니다. 처방용 정형외과 의약품은 통증을 완화하고 염증을 억제하며 치유 과정을 촉진하여 궁극적으로 가동성과 전반적인 삶의 질을 향상시키고 근골격계 장애 관리에 중요한 역할을 합니다. 예를 들어, 2023년 3월 영국 보건복지부 산하 공공보건 기관인 보건향상·격차해소처(Office for Health Improvement and Disparities)는 2022년 기준 16세 이상 인구의 17.6%가 관절염이나 지속적인 허리·관절 문제 등 장기적인 근골격계(MSK) 질환을 앓고 있다고 보고했으며, 이는 2021년 17.0%에서 증가한 수치입니다. 또한 2022년 7월 스위스에 본부를 두고 있는 정부간 기관인 세계보건기구는 세계 약 17억 1천만 명이 근골격계 장애로 고통받고 있다고 추정했습니다. 그 결과, 근골격계 장애의 유병률 증가가 처방용 정형외과 의약품 시장 성장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 처방용 정형외과 의약품 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 처방용 정형외과 의약품 시장 : 성장률 분석
세계의 처방용 정형외과 의약품 시장 실적 : 규모와 성장(2019-2024년)
세계의 처방용 정형외과 의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 처방용 정형외과 의약품 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 처방용 정형외과 의약품 시장 : 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제(NSAIDs)
오피오이드
코르티코스테로이드
질환 수정 항류마티스 약물(DMARD)
기타 약제 유형
세계의 처방용 정형외과 의약품 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
골관절염
류마티스 관절염
골다공증
기타 용도
세계의 처방용 정형외과 의약품 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 처방용 정형외과 의약품 시장 : 비스테로이드성 항염증제(NSAIDs) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
이부프로펜
나프록센
디클로페낙
셀레콕시브
인도메타신
세계의 처방용 정형외과 의약품 시장 : 오피오이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
모르핀
옥시코돈
히드로코돈
펜타닐
트라마돌
세계의 처방용 정형외과 의약품 시장 : 코르티코스테로이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프레드니손
메틸프레드니솔론
덱사메타손
하이드로코르티손
베타메타손
세계의 처방용 정형외과 의약품 시장 : 질환 수정 항류마티스 약물(DMARD) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
메토트렉세이트
하이드록시클로로퀸
레플루노마이드
설파살라진
아자티오프린
세계의 처방용 정형외과 의약품 시장 : 기타 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스포스포네이트
칼시토닌
단일클론항체
근이완제
히알루론산 주사제
제7장 지역별/국가별 분석
세계의 처방용 정형외과 의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 처방용 정형외과 의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
처방용 정형외과 의약품 시장 : 경쟁 구도
처방용 정형외과 의약품 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bayer AG
Sanofi SA
Bristol-Myers Squibb Company
AstraZeneca plc
GSK Plc
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Mylan NV
Biogen Inc.
UCB SA
Allergan plc
Penardo Biotech Pvt. Ltd.
Horizon Therapeutics plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
처방용 정형외과 의약품 시장(2029년) : 새로운 기회를 제공하는 국가
처방용 정형외과 의약품 시장(2029년) : 새로운 기회를 제공하는 부문
처방용 정형외과 의약품 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Prescription orthopedic drugs are medications specifically prescribed to treat musculoskeletal conditions affecting bones, joints, muscles, and ligaments. These drugs help relieve pain, reduce inflammation, and promote healing in orthopedic injuries and disorders such as arthritis, fractures, and tendonitis.
The primary types of prescription orthopedic drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and others. NSAIDs are a class of medications that alleviate pain, inflammation, and fever by inhibiting enzymes responsible for prostaglandin production. These drugs are commonly used to manage conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The prescription orthopedic drugs market research report is one of a series of new reports from The Business Research Company that provides prescription orthopedic drugs market statistics, including the prescription orthopedic drugs industry's global market size, regional shares, competitors with a prescription orthopedic drugs market share, detailed prescription orthopedic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription orthopedic drugs industry. This prescription orthopedic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The prescription orthopedic drugs market size has grown strongly in recent years. It will grow from $48.41 billion in 2024 to $51.06 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the rise in the prevalence of musculoskeletal disorders, the increase in the geriatric population, the growth in awareness of osteoporosis treatments, the expanding healthcare access in developing regions, and the increase in sports-related injuries worldwide.
The prescription orthopedic drugs market size is expected to see strong growth in the next few years. It will grow to $63.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growing demand for biologics, increasing geriatric population, expanding healthcare access in emerging markets, rising prevalence of chronic musculoskeletal disorders, and increasing investments in orthopedic drug research and development. Major trends in the forecast period include advancements in targeted biologics, adoption of regenerative medicine therapies, personalized drug formulations, advancements in minimally invasive delivery methods, enhanced drug efficacy through gene therapy, innovations in injectable formulations, and innovations in artificial intelligence for drug development and clinical decision-making.
The forecast of 5.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for sports medicine practices by increasing costs of viscosupplementation injections and bone healing biologics imported from Sweden and South Korea, potentially delaying post-surgical recovery and raising musculoskeletal care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of musculoskeletal disorders is expected to propel the expansion of the prescription orthopedic drugs market. Musculoskeletal disorders (MSDs) encompass injuries and conditions that impact the movement and function of the body's musculoskeletal system, including muscles, tendons, ligaments, nerves, and joints, leading to pain and restricted mobility. The rising occurrence of these disorders can be attributed to factors such as aging, occupational activities involving repetitive motions and awkward postures, sedentary lifestyles, inadequate nutrition, and genetic predispositions. Prescription orthopedic drugs play a crucial role in managing musculoskeletal disorders by alleviating pain, reducing inflammation, and promoting the healing process, ultimately improving mobility and overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department for public health, reported that 17.6% of individuals aged 16 and older in 2022 had a long-term musculoskeletal (MSK) condition, such as arthritis or persistent back or joint problems, an increase from 17.0% in 2021. Additionally, in July 2022, the World Health Organization, a Switzerland-based intergovernmental organization, estimated that approximately 1.71 billion people worldwide suffer from musculoskeletal disorders. As a result, the increasing prevalence of musculoskeletal disorders is fueling the growth of the prescription orthopedic drugs market.
Leading companies in the prescription orthopedic drugs sector are prioritizing the expansion of indications for their drugs to extend market reach, enhance patient outcomes, and address unmet medical needs across various orthopedic conditions. For instance, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, received FDA approval for the extended use of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, including foot and ankle surgeries. This extended-release formulation is specifically designed to provide prolonged pain relief for up to 72 hours, minimizing or eliminating the need for opioid medications post-surgery. The expanded indication now encompasses a wider range of orthopedic and soft tissue procedures, broadening its use in clinical settings. The drug's innovative dual-drug combination delivers both local anesthetic and anti-inflammatory effects, offering a comprehensive solution for managing post-operative pain while improving patient outcomes.
In April 2024, ProMed Pharma LLC, a US-based pharmaceutical company, acquired SpineThera Inc. for an undisclosed sum. Through this acquisition, ProMed aims to strengthen its drug delivery capabilities by utilizing SpineThera's expertise in extended-release injectable therapies, particularly in pain management for musculoskeletal and orthopedic conditions. SpineThera Inc. is a US-based company specializing in the development of extended-release injectable therapies for treating musculoskeletal conditions, including back pain and orthopedic disorders.
Major players in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc.
North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in prescription orthopedic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the prescription orthopedic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The prescription orthopedic drugs market consists of sales of products such as bisphosphonates, creams, gels, or patches, calcium and vitamin D supplements, and analgesics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prescription Orthopedic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prescription orthopedic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prescription orthopedic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prescription orthopedic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Corticosteroids; Disease-Modifying Antirheumatic Drugs (DMARDs); Other Drug Types
2) By Application: Osteoarthritis; Rheumatoid Arthritis; Osteoporosis; Other Applications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3. Prescription Orthopedic Drugs Market Trends And Strategies
4. Prescription Orthopedic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Prescription Orthopedic Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Prescription Orthopedic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prescription Orthopedic Drugs Market Growth Rate Analysis
5.4. Global Prescription Orthopedic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prescription Orthopedic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prescription Orthopedic Drugs Total Addressable Market (TAM)
6.1. Global Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Opioids
Corticosteroids
Disease-Modifying Antirheumatic Drugs (DMARDs)
Other Drug Types
6.2. Global Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteoarthritis
Rheumatoid Arthritis
Osteoporosis
Other Applications
6.3. Global Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ibuprofen
Naproxen
Diclofenac
Celecoxib
Indomethacin
6.5. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Morphine
Oxycodone
Hydrocodone
Fentanyl
Tramadol
6.6. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Methylprednisolone
Dexamethasone
Hydrocortisone
Betamethasone
6.7. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methotrexate
Hydroxychloroquine
Leflunomide
Sulfasalazine
Azathioprine
6.8. Global Prescription Orthopedic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bisphosphonates
Calcitonin
Monoclonal Antibodies
Muscle Relaxants
Hyaluronic Acid Injections
7. Prescription Orthopedic Drugs Market Regional And Country Analysis
7.1. Global Prescription Orthopedic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prescription Orthopedic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prescription Orthopedic Drugs Market
9.1. China Prescription Orthopedic Drugs Market Overview
9.2. China Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prescription Orthopedic Drugs Market
10.1. India Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prescription Orthopedic Drugs Market
11.1. Japan Prescription Orthopedic Drugs Market Overview
11.2. Japan Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prescription Orthopedic Drugs Market
12.1. Australia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prescription Orthopedic Drugs Market
13.1. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prescription Orthopedic Drugs Market
14.1. South Korea Prescription Orthopedic Drugs Market Overview
14.2. South Korea Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prescription Orthopedic Drugs Market
15.1. Western Europe Prescription Orthopedic Drugs Market Overview
15.2. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prescription Orthopedic Drugs Market
16.1. UK Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Prescription Orthopedic Drugs Market
17.1. Germany Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prescription Orthopedic Drugs Market
18.1. France Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Prescription Orthopedic Drugs Market
19.1. Italy Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Prescription Orthopedic Drugs Market
20.1. Spain Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prescription Orthopedic Drugs Market
21.1. Eastern Europe Prescription Orthopedic Drugs Market Overview
21.2. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prescription Orthopedic Drugs Market
22.1. Russia Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prescription Orthopedic Drugs Market
23.1. North America Prescription Orthopedic Drugs Market Overview
23.2. North America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prescription Orthopedic Drugs Market
24.1. USA Prescription Orthopedic Drugs Market Overview
24.2. USA Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prescription Orthopedic Drugs Market
26.1. South America Prescription Orthopedic Drugs Market Overview
26.2. South America Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prescription Orthopedic Drugs Market
27.1. Brazil Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prescription Orthopedic Drugs Market
28.1. Middle East Prescription Orthopedic Drugs Market Overview
28.2. Middle East Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prescription Orthopedic Drugs Market
29.1. Africa Prescription Orthopedic Drugs Market Overview
29.2. Africa Prescription Orthopedic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prescription Orthopedic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prescription Orthopedic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prescription Orthopedic Drugs Market Competitive Landscape And Company Profiles
